Profarma Distribuidora de Produtos Farmacêuticos S.A. (BVMF:PFRM3)
Brazil · Delayed Price · Currency is BRL 6.91
-0.18 (-2.54%)
Aug 6, 2026, 4:44 PM GMT-3
BVMF:PFRM3 Cash Flow Statement
Financials in millions BRL. Fiscal year is January - December.
Millions BRL. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 154.54 | 118.9 | 114.58 | 70.4 | 80.87 | 78.19 |
Depreciation & Amortization | 194.32 | 179.95 | 152.88 | 133.03 | 124.27 | 112.22 |
Other Amortization | 9.45 | 9.45 | 6.45 | 4.63 | 3.1 | 2.15 |
Asset Writedown & Restructuring Costs | 21.06 | 15.09 | 10.96 | 12.16 | 14.21 | 12.39 |
Loss (Gain) From Sale of Investments | -1.36 | -1.36 | 4.84 | - | -28.85 | - |
Loss (Gain) on Equity Investments | 0.07 | 0.18 | -0.04 | -0.01 | 0.01 | -5.98 |
Provision & Write-off of Bad Debts | 15.78 | 15.88 | 13.32 | 13.13 | 10.83 | 12.26 |
Other Operating Activities | 204.4 | 215.44 | 167.92 | 165.77 | 164.53 | 44 |
Change in Accounts Receivable | -464.59 | -169.22 | -253.24 | -214.99 | -221.7 | -120.17 |
Change in Inventory | -139.6 | -295.71 | -301.05 | -287.6 | -152.83 | -151.02 |
Change in Accounts Payable | 641.52 | 386.88 | 487.8 | 416.92 | 174.54 | 188.62 |
Change in Income Taxes | 13.67 | 10.84 | -5.88 | 10.4 | -21.81 | -39.49 |
Change in Other Net Operating Assets | -76.16 | -26.6 | 98.54 | -62.94 | -20.85 | -25.6 |
Operating Cash Flow | 573.09 | 459.72 | 497.09 | 260.9 | 126.32 | 107.58 |
Operating Cash Flow Growth | 54.77% | -7.52% | 90.53% | 106.53% | 17.43% | 173.42% |
Capital Expenditures | -163.48 | -146.73 | -102.53 | -67.53 | -59.95 | -68.53 |
Cash Acquisitions | 28.11 | - | -13.31 | - | - | - |
Sale (Purchase) of Intangibles | -35.26 | -29.41 | -14.74 | -14.01 | -10.51 | -13.55 |
Investment in Securities | -18.73 | - | -6.26 | -15.04 | 48.72 | -4.33 |
Investing Cash Flow | -189.28 | -176.14 | -136.84 | -96.58 | -21.74 | -86.41 |
Long-Term Debt Issued | - | 1,022 | 468.87 | 1,082 | 891.48 | 552.25 |
Long-Term Debt Repaid | - | -1,036 | -588.99 | -1,047 | -864.34 | -691.86 |
Net Debt Issued (Repaid) | 128.07 | -13.91 | -120.12 | 34.86 | 27.14 | -139.61 |
Common Dividends Paid | -79 | -76.67 | -54.58 | -31.23 | - | -29.12 |
Other Financing Activities | -191.67 | -187.43 | -149.74 | -157.46 | -136.98 | -35.72 |
Financing Cash Flow | -142.6 | -278.01 | -324.44 | -153.83 | -109.84 | -204.44 |
Net Cash Flow | 241.21 | 5.57 | 35.81 | 10.49 | -5.26 | -183.28 |
Free Cash Flow | 409.61 | 312.98 | 394.56 | 193.37 | 66.37 | 39.04 |
Free Cash Flow Growth | 63.79% | -20.68% | 104.05% | 191.35% | 69.99% | 1083.15% |
Free Cash Flow Margin | 3.28% | 2.73% | 3.89% | 2.23% | 0.85% | 0.61% |
Free Cash Flow Per Share | - | 2.55 | 3.22 | 1.58 | 0.54 | 0.32 |
Levered Free Cash Flow | -319.42 | 65.89 | 173.12 | -16.86 | -63.83 | -10.87 |
Unlevered Free Cash Flow | -154.2 | 191.62 | 266.49 | 84.33 | 29.42 | 36.73 |
Cash Interest Paid | 187.43 | 187.43 | 149.74 | 157.46 | 136.98 | 35.72 |
Cash Income Tax Paid | - | -12.9 | 13.22 | 8.93 | 5.06 | 0.59 |
Change in Working Capital | -25.16 | -93.81 | 26.17 | -138.21 | -242.65 | -147.66 |